Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Catalona, 2018, Prostate cancer screening, Med Clin North Am, 102, 199, 10.1016/j.mcna.2017.11.001 Matoso, 2019, Defining clinically significant prostate cancer on the basis of pathological findings, Histopathology, 74, 135, 10.1111/his.13712 Mahal, 2019, Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010–2015, JAMA, 321, 704, 10.1001/jama.2018.19941 Amin, 2014, Arch Pathol Lab Med, 138, 1387, 10.5858/arpa.2014-0219-SA Montironi, 2014, Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist, Virchows Arch, 465, 623, 10.1007/s00428-014-1668-5 Varma, 2018, Contemporary prostate biopsy reporting: insights from a survey of clinicians' use of pathology data, J Clin Pathol, 71, 874, 10.1136/jclinpath-2018-205093 Kronz, 2003, Lesions missed on prostate biopsies in cases sent in for consultation, Prostate, 54, 310, 10.1002/pros.10182 Brimo, 2010, The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy, J Urol, 184, 126, 10.1016/j.juro.2010.03.021 Renshaw, 2003, Agreement and error rates using blinded review to evaluate surgical pathology of biopsy material, Am J Clin Pathol, 119, 797, 10.1309/DCXAXFVCCHVHYU41 Renshaw, 2006, Measuring the value of review of pathology material by a second pathologist, Am J Clin Pathol, 125, 737, 10.1309/6A0RAX9KCR8VWCG4 Metter, 2019, Trends in the US and Canadian pathologist workforces from 2007 to 2017, JAMA Netw Open, 2, e194337, 10.1001/jamanetworkopen.2019.4337 Campanella, 2019, Clinical-grade computational pathology using weakly supervised deep learning on whole slide images, Nat Med, 25, 1301, 10.1038/s41591-019-0508-1 Litjens G, Sánchez CI, Timofeeva N, Hermsen M, Nagtegaal I, Kovacs I, et al. Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis. Sci Rep. 2016;6. https://doi.org/10.1038/srep26286. Trajman, 2008, McNemar χ2 test revisited: comparing sensitivity and specificity of diagnostic examinations, Scand J Clin Lab Invest, 68, 77, 10.1080/00365510701666031 Yang C, Humphrey PA. False-negative histopathologic diagnosis of prostatic adenocarcinoma. Arch Pathol Lab Med 2019. https://doi.org/10.5858/arpa.2019-0456-RA. van der Kwast, 2003, Report of the Pathology Committee: false-positive and false-negative diagnoses of prostate cancer, BJU Int, 92, 62, 10.1111/j.1465-5101.2003.04400.x Steiner, 2018, Impact of deep learning assistance on the histopathologic review of lymph nodes for metastatic breast cancer, Am J Surg Pathol, 42, 1636, 10.1097/PAS.0000000000001151